|Articles|January 1, 2003

Glaucoma drugs may pose risk to ocular surface

Author(s)Julia Talsma

Orlando-Ophthalmologists should be aware of the risks to the ocular surface associated with long-term use of glaucoma medications, according to Robert J. Noecker, MD, MBA, who also spoke at the Cornea Health symposium during the American Academy of Ophthalmology annual meeting.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME